The findings of equipotent sensitivity profiles of NVP-BGT226 and NVP-BEZ235 with regard to inhibition of cellular proliferation in native AKT-activated leukemia cells are in line with our in vitro data provided above. This evidence concerns the gene AKT1 and leukemia.